Doximity (NASDAQ:DOCS) Research Coverage Started at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Doximity (NASDAQ:DOCSFree Report) in a research note issued to investors on Friday morning, MarketBeat Ratings reports. The firm issued a neutral rating and a $58.00 price objective on the stock.

Several other analysts have also recently weighed in on the company. KeyCorp raised Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 price target on the stock in a report on Friday, November 8th. Canaccord Genuity Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and raised their target price for the company from $40.00 to $60.00 in a research note on Wednesday, November 13th. Robert W. Baird boosted their price target on shares of Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 17th. Evercore ISI raised their price objective on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Finally, Needham & Company LLC raised shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price objective for the company in a report on Friday, August 9th. Eleven investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $51.07.

Check Out Our Latest Report on Doximity

Doximity Stock Performance

Doximity stock opened at $49.40 on Friday. Doximity has a fifty-two week low of $22.96 and a fifty-two week high of $61.75. The stock has a market cap of $9.22 billion, a P/E ratio of 56.78, a PEG ratio of 4.09 and a beta of 1.30. The firm’s fifty day moving average price is $43.40 and its 200-day moving average price is $34.25.

Institutional Trading of Doximity

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC grew its stake in shares of Doximity by 19.8% in the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after purchasing an additional 472,565 shares during the last quarter. M&T Bank Corp purchased a new stake in Doximity in the third quarter worth $351,000. Barclays PLC boosted its holdings in Doximity by 60.5% in the third quarter. Barclays PLC now owns 53,401 shares of the company’s stock valued at $2,327,000 after acquiring an additional 20,125 shares in the last quarter. Orion Portfolio Solutions LLC purchased a new position in Doximity during the 3rd quarter valued at $260,000. Finally, State Street Corp raised its holdings in Doximity by 2.5% in the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company’s stock worth $160,947,000 after purchasing an additional 88,922 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Doximity Company Profile

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Stories

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.